Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18539,153,0.95 [0.75-1.21],0.6827545437563932
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19487,201,0.88 [0.70-1.10],0.2506254059748508
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19265,1408,0.94 [0.87-1.02],0.113717635867047
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Candidiasis,19504,446,0.94 [0.82-1.09],0.4121176850416619
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18860,3448,1.01 [0.97-1.06],0.5344926616453338
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18844,3494,1.05 [1.00-1.10],0.0461117848043047
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19259,1150,1.07 [0.99-1.15],0.0923722823971237
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19417,108,0.67 [0.46-0.98],0.040925951327088
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17206,1018,1.07 [0.98-1.16],0.1327433229351463
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16578,1231,1.00 [0.93-1.09],0.9189896023926598
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16242,269,0.92 [0.76-1.11],0.3899827304385744
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12703,2208,1.04 [0.98-1.10],0.1839753829945164
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16191,393,1.01 [0.87-1.16],0.9381823316433509
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19469,1360,1.04 [0.96-1.11],0.3472077829681381
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Mycoses,19575,517,0.98 [0.87-1.12],0.7870681912547314
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18852,995,0.95 [0.87-1.05],0.3149996881940704
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19516,1130,1.04 [0.96-1.13],0.3067485575463462
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18310,201,0.88 [0.70-1.10],0.2564062500886663
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19624,50,0.96 [0.63-1.46],0.8460899763895444
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19368,982,1.07 [0.99-1.16],0.0993625413977297
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19371,62,1.02 [0.72-1.44],0.9197397837326544
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19567,110,0.96 [0.72-1.26],0.750763560418682
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19553,96,0.95 [0.71-1.29],0.7559250810098253
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18235,378,0.86 [0.72-1.01],0.072189461247999
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18107,250,0.96 [0.80-1.16],0.7052979997837463
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18208,99,0.83 [0.59-1.16],0.2782789118911365
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19610,45,1.29 [0.96-1.73],0.0923553420975146
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19564,152,1.11 [0.91-1.36],0.2918656115759075
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Viral warts,19461,49,1.16 [0.83-1.63],0.3767478869494822
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19484,72,1.06 [0.78-1.44],0.7295799005001252
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm,19378,224,1.18 [1.02-1.38],0.0297893509691205
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19551,37,1.47 [1.13-1.92],0.0041091352401017
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19537,41,1.06 [0.70-1.60],0.7807629178658002
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9282,69,1.24 [0.95-1.61],0.1147637168410069
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19239,1410,0.98 [0.91-1.06],0.6415561707223224
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of meninges,19610,54,1.00 [0.69-1.46],0.991866496478312
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19543,67,0.89 [0.61-1.31],0.5580167558605064
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19603,92,1.23 [0.98-1.54],0.0678074174418082
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm of ovary,10292,63,0.80 [0.52-1.24],0.3180388902607769
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19589,377,0.88 [0.74-1.03],0.1181796911977129
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Caecum,19603,322,0.95 [0.80-1.12],0.5208361100477066
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19500,74,0.89 [0.61-1.29],0.5310096769544868
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Descending colon,19588,221,0.94 [0.77-1.15],0.5733804586742394
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Rectum,19546,344,1.04 [0.90-1.20],0.6232001634269295
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19494,591,1.04 [0.93-1.16],0.5111736571952945
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19583,451,0.85 [0.72-0.99],0.0370964205348855
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Carcinoma in situ of breast,7742,44,0.47 [0.23-0.97],0.0408371811477881
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7775,54,0.51 [0.27-0.96],0.0368871561196616
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14064,63,0.81 [0.52-1.26],0.3415767064373281
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14083,82,1.18 [0.92-1.51],0.2027066103697632
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19572,108,1.02 [0.78-1.33],0.882714668704423
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Haemangioma, any site",19573,105,1.02 [0.78-1.33],0.866399938666454
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Leiomyoma of uterus,10056,144,0.91 [0.70-1.17],0.4525310286200521
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Lung cancer and mesothelioma,12515,424,1.07 [0.94-1.22],0.285470810494312
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Lymphoid leukaemia,14065,64,0.74 [0.46-1.19],0.209271788077792
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14188,187,1.03 [0.85-1.26],0.7333176898845375
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14258,257,0.93 [0.77-1.12],0.4527873632173416
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7852,92,1.03 [0.78-1.36],0.8284494899793143
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14096,95,1.04 [0.79-1.37],0.7686069914867206
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14121,120,0.95 [0.73-1.25],0.7204942827316405
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14110,109,1.28 [1.06-1.53],0.0098925653289722
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7841,81,1.06 [0.81-1.39],0.6685298030341226
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14108,107,0.91 [0.67-1.23],0.5345270868972709
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7040,799,0.95 [0.86-1.06],0.395482158192152
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14110,109,0.95 [0.71-1.26],0.7015882858731843
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14078,77,1.16 [0.89-1.51],0.2773572199260022
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14119,118,1.16 [0.93-1.44],0.18265181911842
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanocytic naevi,19500,155,1.02 [0.81-1.27],0.8848670279759069
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanocytic naevi of trunk,19600,66,0.98 [0.69-1.40],0.9304948559747052
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Melanoma in situ,14048,97,1.11 [0.87-1.42],0.3897175361902617
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14103,102,1.14 [0.90-1.44],0.2698299112220543
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14167,166,1.02 [0.82-1.26],0.865290140420288
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14296,295,1.05 [0.90-1.22],0.5566882878431408
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14108,107,1.06 [0.83-1.36],0.6485065669230814
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,Other benign neoplasms of skin,19477,146,1.11 [0.91-1.36],0.3142248310331774
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15250,1249,1.05 [0.97-1.13],0.2292527779805123
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15317,1316,1.05 [0.97-1.13],0.22993384042172
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19375,319,0.98 [0.84-1.15],0.831411279162371
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17725,107,1.14 [0.91-1.44],0.2628656060455611
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19117,61,0.90 [0.60-1.34],0.592121037707988
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19027,2872,1.04 [0.99-1.09],0.1234189908491903
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18235,57,0.85 [0.54-1.34],0.4865168902759145
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19242,57,1.10 [0.79-1.54],0.5630502489213813
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19231,1613,1.01 [0.94-1.08],0.7719412049421872
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19229,1611,1.01 [0.94-1.08],0.7618149486519393
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17711,93,0.99 [0.73-1.33],0.9316447627498794
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19328,1150,1.07 [0.99-1.16],0.0770386796447268
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19285,100,1.03 [0.78-1.35],0.8344167158546292
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19111,55,0.87 [0.57-1.35],0.5396788413320452
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19124,68,0.74 [0.47-1.18],0.2040781836349906
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19470,285,1.05 [0.90-1.23],0.5205416838603248
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19519,33,0.91 [0.53-1.57],0.7434314900864593
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19419,234,1.00 [0.83-1.20],0.9591447333436972
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18290,112,1.05 [0.82-1.35],0.7112375226444944
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13266,329,0.99 [0.84-1.16],0.8797748713240001
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18367,85,0.56 [0.33-0.95],0.0320466397600882
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18375,93,0.96 [0.71-1.31],0.8103533432613328
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12998,61,1.23 [0.93-1.62],0.1486081305364044
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18272,44,0.90 [0.57-1.44],0.6721309903907683
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17644,260,0.98 [0.82-1.17],0.8302479780746042
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18986,744,0.94 [0.84-1.05],0.2530641286111875
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18644,402,0.71 [0.59-0.87],0.0006175133278182
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18391,149,1.06 [0.85-1.32],0.5996636323428517
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19398,1170,0.95 [0.88-1.04],0.287489345885711
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16609,1140,0.96 [0.88-1.05],0.3423151410538415
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13005,68,1.14 [0.86-1.52],0.3505189251994725
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17741,84,0.86 [0.60-1.22],0.4038571839773346
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13228,291,1.06 [0.91-1.23],0.4875739151340301
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12985,48,1.11 [0.78-1.58],0.5465913597838951
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16770,3833,0.96 [0.92-1.01],0.1015579164805394
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13167,230,0.99 [0.82-1.19],0.884929495806967
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13522,585,0.99 [0.88-1.12],0.9088285512550588
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19578,300,1.04 [0.89-1.21],0.6521659409301035
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19401,123,1.10 [0.88-1.38],0.383585433890484
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13065,128,0.81 [0.60-1.10],0.1854620691749354
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13006,69,0.76 [0.49-1.18],0.2180356281064772
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19091,1434,0.96 [0.89-1.04],0.2807387850103016
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13242,305,1.02 [0.87-1.19],0.8221872770751085
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13260,323,1.05 [0.90-1.22],0.5251354213990136
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13649,712,1.04 [0.94-1.15],0.4057755729363623
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13063,126,1.09 [0.87-1.37],0.4604598954107979
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19395,117,1.13 [0.90-1.41],0.2952414989548895
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13686,749,1.05 [0.96-1.16],0.2736330199870769
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13482,545,1.00 [0.89-1.13],0.993686339114028
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17443,59,0.80 [0.51-1.26],0.3388586473878003
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18320,5383,0.98 [0.94-1.02],0.2494758799403235
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17706,49,0.85 [0.53-1.36],0.5028803928174124
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17700,43,0.96 [0.61-1.49],0.8446570951912258
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19477,1565,0.97 [0.91-1.05],0.4645768686667393
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19475,1563,0.97 [0.91-1.04],0.4467119278927107
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17712,55,0.72 [0.44-1.20],0.2079201316432952
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19329,960,0.94 [0.85-1.03],0.1851717150673617
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14771,1834,1.01 [0.94-1.08],0.8133714832301612
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19614,238,0.95 [0.78-1.15],0.6038676746093652
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18334,92,1.19 [0.93-1.51],0.1671812920592049
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18468,99,1.17 [0.93-1.48],0.1888111961590478
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18512,143,1.22 [1.02-1.46],0.0295436347095711
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13098,161,1.11 [0.92-1.34],0.2906191638777591
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17277,157,1.03 [0.83-1.28],0.7801546587950897
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2095,81,0.99 [0.73-1.35],0.9546812895900634
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2234,253,1.12 [0.97-1.31],0.1302944810427913
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17188,68,0.84 [0.56-1.25],0.3959563136845766
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2063,50,0.77 [0.47-1.25],0.293796200459717
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18933,1813,1.00 [0.93-1.06],0.9095724406660634
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18737,495,0.98 [0.86-1.11],0.717806348379874
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17745,361,1.06 [0.92-1.22],0.3953325160992479
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13828,891,0.97 [0.88-1.06],0.4851734817917109
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19510,261,1.01 [0.85-1.20],0.9331504834658068
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18404,224,1.10 [0.92-1.30],0.302970293188918
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Angina pectoris,17012,1286,0.97 [0.89-1.05],0.4561729396891884
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18491,311,1.09 [0.94-1.27],0.2337414816432618
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18248,68,1.19 [0.90-1.57],0.2310873126079097
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18414,234,1.08 [0.91-1.28],0.3748409181651877
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9998,2324,1.03 [0.97-1.09],0.3296515701033363
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,AV-block,15036,547,1.07 [0.95-1.19],0.2592444669828617
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19552,465,0.95 [0.83-1.09],0.4556509643961246
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cardiac arrest,7890,216,1.15 [0.97-1.38],0.1133714751627802
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14662,173,0.89 [0.70-1.14],0.3539132181667124
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14578,89,0.90 [0.64-1.26],0.540015998356772
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19618,59,1.06 [0.74-1.50],0.7573793414088839
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Conduction disorders,15760,1271,1.02 [0.95-1.11],0.5746993999634956
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18006,2302,0.99 [0.93-1.05],0.6924753100626587
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15893,7543,1.00 [0.97-1.04],0.7693470053068104
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18324,287,1.01 [0.86-1.19],0.8803346230859945
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Endocarditis,14566,77,0.85 [0.58-1.24],0.3917129110688976
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19381,1366,1.03 [0.95-1.11],0.4795534195705757
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypertension,16935,6681,1.00 [0.97-1.04],0.8149171205489365
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16939,6685,1.00 [0.97-1.04],0.7831957449219198
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19481,85,1.08 [0.82-1.43],0.5788626920912927
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10493,239,0.90 [0.73-1.12],0.3544811992020092
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10378,124,1.10 [0.86-1.41],0.4459134774147651
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Hypotension,19472,1302,1.04 [0.97-1.12],0.2889285356882319
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18567,118,1.00 [0.77-1.30],0.9961471182572448
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18165,2439,0.98 [0.92-1.04],0.4671630499244912
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19210,660,1.02 [0.92-1.14],0.6601174343153744
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14912,423,1.15 [1.03-1.29],0.0157347697774406
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19070,875,1.01 [0.92-1.11],0.7931337084364053
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16481,755,1.00 [0.90-1.10],0.9302943817346594
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19511,163,0.98 [0.78-1.23],0.877897653258734
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19586,339,1.06 [0.91-1.22],0.457788537066876
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Oesophageal varices,18094,57,1.28 [0.97-1.70],0.0794224614108412
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other aneurysm,18266,86,0.98 [0.72-1.34],0.9115914120095464
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other arrhythmias,14978,489,1.12 [1.01-1.25],0.0403907910347021
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18288,108,1.07 [0.83-1.38],0.5775199333567419
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18445,265,1.14 [0.98-1.32],0.0818302596032137
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14677,188,1.12 [0.94-1.34],0.1963697809986052
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other disorders of veins,18125,88,0.88 [0.62-1.25],0.4782048434045696
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18075,38,1.09 [0.72-1.66],0.6824685383575009
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17949,72,0.81 [0.54-1.22],0.3140934727774302
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18176,139,0.96 [0.74-1.23],0.7210747275802887
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15667,1178,1.02 [0.94-1.11],0.6135343502176149
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18220,50,0.97 [0.64-1.47],0.8818597647463142
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18774,594,1.03 [0.92-1.15],0.6520073316358932
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18985,452,1.05 [0.93-1.19],0.4413321811070706
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18670,793,1.04 [0.94-1.14],0.468773119096475
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8013,339,1.07 [0.92-1.24],0.3904636252633255
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18636,486,1.06 [0.94-1.20],0.3073619843808623
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18397,360,1.08 [0.95-1.24],0.2468971548859971
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19026,493,1.07 [0.95-1.20],0.2928246791150254
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19535,795,0.99 [0.90-1.10],0.8930031168479262
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14915,426,0.93 [0.80-1.08],0.331815660728073
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18980,447,1.06 [0.93-1.20],0.3858802992815953
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18087,210,1.12 [0.95-1.33],0.1759688256624398
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19194,745,1.02 [0.92-1.13],0.704663863940806
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19181,776,1.01 [0.92-1.12],0.7885396117800716
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18539,48,0.84 [0.52-1.37],0.4903074292821269
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18262,82,1.06 [0.79-1.42],0.7161597907567866
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18804,254,1.03 [0.87-1.22],0.7144200137024086
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18461,266,1.07 [0.92-1.26],0.3853866181988159
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Varicose veins,18463,426,0.99 [0.86-1.14],0.8920936580266796
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18195,99,0.96 [0.72-1.29],0.7905851275276083
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19389,784,1.07 [0.98-1.18],0.1321396194153996
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19556,279,0.98 [0.82-1.16],0.8090580062923277
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16865,1165,0.99 [0.91-1.08],0.8433168667229065
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Any mental disorder,19191,3491,0.99 [0.94-1.04],0.741887834122491
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19533,328,0.94 [0.79-1.11],0.4499522856925148
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16891,1191,0.96 [0.88-1.04],0.3326017957112934
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15763,63,0.84 [0.55-1.29],0.4270547316359342
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Smoking dependency,19188,973,1.03 [0.94-1.12],0.5655810175376099
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16908,1208,1.03 [0.95-1.11],0.4939930968674326
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter V Mental and behavioural disorders,Vascular dementia,18923,194,0.74 [0.56-0.96],0.0260555535868467
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Alzheimer disease,19621,495,0.75 [0.63-0.88],0.000674157558747
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12230,89,0.55 [0.34-0.89],0.0152620830290565
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Bell's palsy,18098,70,1.14 [0.86-1.52],0.352075319119932
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18443,415,0.95 [0.82-1.10],0.4994752631991477
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Cerebral cysts,19256,198,1.04 [0.86-1.27],0.6551935446691879
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19560,325,1.04 [0.90-1.21],0.5727877859936836
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18937,73,0.87 [0.59-1.28],0.4851855254018813
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19605,60,1.07 [0.76-1.50],0.7075328326163782
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19124,66,1.00 [0.70-1.43],0.9985914866878352
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Epilepsy,18387,247,0.85 [0.69-1.05],0.1375073245533094
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19239,1099,0.97 [0.89-1.06],0.493938531848782
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19573,537,1.07 [0.96-1.20],0.2201367053591077
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19073,2804,0.99 [0.94-1.05],0.7373447095683575
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Generalized epilepsy,19318,45,0.57 [0.30-1.11],0.1000277053328637
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Hemiplegia,19501,266,1.05 [0.89-1.23],0.5806567932359713
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Hydrocephalus,19118,60,1.04 [0.74-1.47],0.8007389836320491
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19610,58,0.97 [0.66-1.42],0.8626816963398125
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18088,60,0.94 [0.64-1.39],0.7684766353094609
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18087,59,1.18 [0.87-1.59],0.2891953287384605
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Memory loss,18710,128,1.13 [0.92-1.40],0.249352585413532
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Migraine,18375,235,0.96 [0.79-1.16],0.6707731001345435
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19579,214,0.98 [0.81-1.19],0.8485040740395032
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Motor neuron disease,12327,165,1.21 [1.01-1.44],0.0380604855652429
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19515,51,0.94 [0.62-1.43],0.7884297216710645
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19032,1004,0.96 [0.88-1.06],0.4460229740384104
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Neurological diseases,18380,3467,0.99 [0.95-1.04],0.8287254767195281
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19105,241,1.06 [0.89-1.26],0.4995665440606751
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18356,328,1.05 [0.91-1.21],0.5274580921270802
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19552,285,0.91 [0.75-1.09],0.2961588946204819
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14892,796,0.90 [0.80-1.01],0.0629008966979814
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19125,67,0.80 [0.52-1.23],0.2993114019336317
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19190,132,1.09 [0.88-1.36],0.4339535142670372
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19214,178,0.99 [0.80-1.23],0.9604295504533142
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18105,77,1.13 [0.85-1.48],0.4016093387936837
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other headache syndromes,18184,44,1.12 [0.77-1.62],0.5634247396855393
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other neurological diseases,19527,469,1.03 [0.91-1.17],0.6402092685160465
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Other sleep disorders,18556,416,0.92 [0.79-1.06],0.2571029115826219
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Parkinson's disease,19590,339,1.11 [0.96-1.27],0.152527113946656
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19096,38,1.19 [0.84-1.70],0.3280679882771354
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Restless leg syndrome,19620,79,0.83 [0.57-1.22],0.3399941996711868
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Sleep apnoea,19435,359,0.94 [0.80-1.10],0.4140267088231608
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19317,50,0.92 [0.60-1.43],0.7180371663861296
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19609,185,1.15 [0.97-1.37],0.1079873927971416
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18087,59,0.84 [0.55-1.30],0.4400202828756285
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19621,500,0.75 [0.63-0.88],0.0005958076834605
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18868,188,0.74 [0.56-0.98],0.0325866658206147
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19087,124,1.00 [0.78-1.28],0.9797103760568914
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19257,475,0.90 [0.78-1.04],0.1732396679444705
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19419,222,1.12 [0.95-1.32],0.1921269921300989
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18574,58,1.15 [0.84-1.58],0.3728372271909396
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18551,35,0.99 [0.61-1.61],0.958456679648546
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19520,60,1.28 [0.99-1.66],0.0623004834011726
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19355,191,0.97 [0.78-1.20],0.7732757688438376
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2067,53,0.78 [0.49-1.25],0.3033185998618732
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2542,92,0.95 [0.70-1.28],0.7250107925496726
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19057,94,1.07 [0.82-1.39],0.634894731193449
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19389,1200,1.02 [0.94-1.10],0.6766652024492519
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19267,751,1.02 [0.92-1.13],0.7412259927002216
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18771,255,1.09 [0.93-1.28],0.2717909217428386
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19567,785,0.97 [0.87-1.07],0.539466509704684
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19615,67,1.13 [0.84-1.52],0.4219863329368337
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19515,733,0.94 [0.84-1.05],0.2797181012122964
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19587,423,1.02 [0.90-1.17],0.7383505724354383
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19520,186,0.86 [0.68-1.10],0.2223587312331231
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18603,87,0.92 [0.66-1.29],0.6211734165976077
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18603,87,0.98 [0.72-1.34],0.9171967057120168
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18583,67,0.90 [0.61-1.32],0.5779318990277973
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19504,848,1.03 [0.94-1.13],0.4833849118501444
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18883,227,1.01 [0.84-1.22],0.917510046434944
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18840,58,0.78 [0.49-1.25],0.3037340263512645
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19271,107,1.01 [0.77-1.32],0.9403899716454396
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19493,329,1.03 [0.89-1.20],0.6718869894174739
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18963,181,1.05 [0.87-1.28],0.6137981825892671
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19449,115,0.93 [0.70-1.24],0.6304957524465016
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19210,554,1.02 [0.91-1.15],0.6896867010068237
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19098,135,1.00 [0.78-1.27],0.9842503747893526
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17563,2735,1.09 [1.03-1.14],0.0012568850621406
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19456,292,1.02 [0.87-1.20],0.7886297990409739
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19606,156,0.90 [0.70-1.15],0.3895403296943756
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18980,464,0.97 [0.84-1.11],0.6348475697350766
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19245,81,1.09 [0.82-1.45],0.5398681759900541
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19607,59,1.19 [0.88-1.59],0.2552404605508869
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18624,108,1.09 [0.85-1.39],0.5137006308642298
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18669,153,0.81 [0.61-1.08],0.1473532355806025
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18326,137,0.86 [0.65-1.14],0.2979632262107467
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18829,47,1.48 [1.17-1.87],0.0011148493026492
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18253,64,1.16 [0.86-1.56],0.3292446400617705
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18753,97,1.05 [0.80-1.37],0.7489372440938797
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18902,246,1.08 [0.91-1.27],0.3909078624737878
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18647,131,1.07 [0.85-1.35],0.5494163752815224
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18266,77,0.90 [0.63-1.29],0.5745207969811663
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18292,103,1.01 [0.77-1.33],0.9354394339871056
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17103,2275,1.00 [0.94-1.06],0.9200297608104244
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18594,78,1.06 [0.78-1.43],0.721479186413426
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19385,422,1.01 [0.88-1.16],0.8782960650292782
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19029,66,1.09 [0.80-1.50],0.5722588354936553
RAC3,Ras-related C3 botulinum toxin substrate 3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19122,159,1.04 [0.85-1.29],0.6838279783533091
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19428,94,0.84 [0.59-1.18],0.3100795940235511
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19586,119,0.94 [0.72-1.24],0.6763650024737207
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19512,94,0.96 [0.71-1.30],0.7774132045047918
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19391,57,0.84 [0.54-1.32],0.4522289844359677
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19395,61,0.58 [0.33-1.01],0.0558312929163803
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19529,1004,1.02 [0.93-1.11],0.6685112435459735
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19286,761,1.03 [0.94-1.14],0.4978747247433951
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18648,123,1.06 [0.84-1.35],0.6118663932264293
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18600,75,1.07 [0.79-1.44],0.6679248235440409
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute pharyngitis,19452,48,0.89 [0.56-1.41],0.621293246963416
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19555,151,0.84 [0.64-1.10],0.1979102575707702
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19456,52,1.05 [0.73-1.51],0.8005160885273622
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,All influenza,17417,126,0.99 [0.77-1.27],0.9280147895690438
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17414,123,1.01 [0.79-1.30],0.9347229054834142
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12176,85,1.14 [0.88-1.49],0.3250171558628676
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Allergic rhinitis,19540,202,1.06 [0.88-1.28],0.5141183939649061
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13254,1480,1.04 [0.97-1.11],0.3107109864759878
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13553,1462,1.04 [0.97-1.12],0.2759989952694949
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19180,150,0.82 [0.62-1.09],0.1760442152531335
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17376,85,0.74 [0.49-1.11],0.1478956162813064
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Bronchiectasis,16425,432,0.99 [0.87-1.14],0.912084986273112
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16055,62,1.29 [1.00-1.66],0.0532829325400493
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18668,2675,1.04 [0.99-1.09],0.137037302073433
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18578,65,0.73 [0.45-1.16],0.1839448414799681
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Chronic sinusitis,18626,113,0.70 [0.48-1.01],0.0565461704381182
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19375,1352,1.03 [0.95-1.11],0.4909695213492362
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Deviated nasal septum,18584,71,0.80 [0.52-1.21],0.290644537984513
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17798,5101,1.01 [0.97-1.05],0.5198136219589105
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18806,293,0.95 [0.79-1.13],0.5261505127768973
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Early onset COPD,18121,98,0.90 [0.66-1.22],0.504181413599727
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Emphysema,16360,367,1.08 [0.95-1.24],0.2351592655635217
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18492,403,1.01 [0.88-1.16],0.9161545044553058
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19392,2101,0.99 [0.93-1.05],0.7109138465903647
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Interstitial lung disease,18527,438,1.00 [0.87-1.14],0.9590147442337932
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Later onset COPD,19170,1254,1.04 [0.96-1.12],0.3443718030352176
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19605,378,1.10 [0.97-1.26],0.1494056301964638
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Nasal polyp,18598,85,0.89 [0.62-1.26],0.501092352341816
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19379,1051,0.99 [0.90-1.08],0.7788404877554824
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other diseases of pleura,19375,2227,1.05 [0.99-1.11],0.0912788595137554
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19159,646,0.95 [0.85-1.07],0.4003143211592392
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other pleural conditions,17203,55,0.96 [0.64-1.43],0.8469903126634273
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19508,513,0.94 [0.83-1.08],0.3960442616059131
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19507,1434,1.05 [0.98-1.13],0.1601539297187211
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pleural effusion,18251,1103,1.09 [1.01-1.17],0.0298676886126972
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pleural plaque,17369,221,1.08 [0.90-1.30],0.3870351462617789
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19155,1864,0.99 [0.93-1.06],0.8082746359066312
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19512,285,1.11 [0.96-1.29],0.1653238401657105
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pneumothorax,17296,148,1.05 [0.84-1.30],0.6926154898963954
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pollen allergy,19612,172,0.98 [0.79-1.22],0.8817945305557667
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Pulmonary oedema,19069,74,0.60 [0.36-0.98],0.0414513907621568
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12150,59,1.10 [0.79-1.53],0.5843263015483325
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19363,1035,0.98 [0.90-1.08],0.7388307065357492
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18716,203,1.05 [0.88-1.27],0.5755425833338896
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Viral pneumonia,17532,241,0.96 [0.79-1.16],0.6516328144671316
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19192,193,0.95 [0.77-1.18],0.6631250540662756
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6329,101,0.99 [0.73-1.35],0.9716796363250364
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12552,52,1.08 [0.75-1.55],0.6685338664120881
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute appendicitis,19519,108,0.77 [0.54-1.09],0.1407666644521116
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute gastritis,13718,83,0.83 [0.57-1.21],0.3336093170311564
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute pancreatitis,17933,164,0.94 [0.75-1.19],0.6320110182584622
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Acute peritonitis,19222,91,1.02 [0.76-1.36],0.8928948197410751
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18800,49,1.32 [1.00-1.74],0.0497354414909794
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Barrett oesophagus,14051,416,1.01 [0.88-1.16],0.8741901596843503
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17890,121,0.85 [0.63-1.15],0.301827284081241
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19277,121,0.85 [0.63-1.15],0.299878550336912
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Cholecystitis,17948,179,0.86 [0.68-1.10],0.2405665944053669
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Cholelithiasis,18655,886,1.02 [0.93-1.12],0.6440208787607735
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Chronic gastritis,13930,295,0.95 [0.80-1.13],0.547924434851889
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17815,46,0.90 [0.56-1.44],0.6544378277518362
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19505,109,1.06 [0.82-1.37],0.648179051575648
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Coeliac disease,18179,104,1.25 [1.02-1.52],0.0288746767099744
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Collagenous colitis,18154,88,0.96 [0.71-1.31],0.8014004023209822
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19523,141,0.93 [0.72-1.21],0.6053479173499032
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Constipation,19382,1731,0.94 [0.87-1.01],0.0774187545713885
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Crohn disease,18132,66,0.79 [0.51-1.22],0.2852373871027491
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19331,52,0.71 [0.41-1.21],0.2064138750783341
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18127,61,0.79 [0.50-1.24],0.3110572697320378
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Dental caries,19097,156,0.91 [0.71-1.17],0.4772529925667775
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16994,2148,0.96 [0.91-1.03],0.2584591220043463
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of appendix,19544,133,0.86 [0.64-1.14],0.2968700296848297
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of liver,19524,773,1.03 [0.93-1.13],0.61032491740875
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17482,3847,1.00 [0.96-1.05],0.9610393427300664
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19338,397,1.01 [0.87-1.16],0.9252206790812894
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19549,418,1.04 [0.91-1.18],0.5986565641426635
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19016,75,0.91 [0.63-1.30],0.6041385156319284
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18914,44,0.71 [0.39-1.27],0.2462694820472344
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19353,1278,1.02 [0.94-1.10],0.667178567038492
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diseases of tongue,18925,77,0.98 [0.70-1.37],0.8976530468458351
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19041,1272,1.02 [0.94-1.10],0.6372694166379983
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15697,3197,1.00 [0.95-1.05],0.8707122946358814
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Duodenal ulcer,13837,202,0.96 [0.78-1.18],0.7030626043923289
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19532,161,1.00 [0.80-1.25],0.969088416532168
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19594,18,0.86 [0.39-1.89],0.7049897456974571
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18878,127,1.11 [0.89-1.38],0.3507678949993572
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12595,95,0.93 [0.68-1.27],0.6534072679668539
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Functional dyspepsia,14108,473,0.93 [0.81-1.07],0.3066452167984876
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastric ulcer,13992,357,0.94 [0.80-1.10],0.4454452725799004
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15858,2223,1.04 [0.98-1.10],0.1655343829285603
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14179,544,0.97 [0.85-1.10],0.5935841243915758
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14254,6944,1.00 [0.97-1.04],0.8524158349959782
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,GI-bleeding,19122,1047,1.00 [0.92-1.09],0.9521083118237296
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18985,44,1.17 [0.82-1.66],0.3849304920911507
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13346,1010,0.96 [0.87-1.05],0.3933764331501312
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18809,58,1.17 [0.87-1.59],0.3023037652131887
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Hernia,17890,3044,0.97 [0.92-1.02],0.2452728903949268
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Impacted teeth,19596,17,0.90 [0.41-1.96],0.7832327078334106
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Impaction of intestines,12565,65,1.01 [0.71-1.43],0.9538037236907044
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Inguinal hernia,15760,914,1.01 [0.92-1.12],0.7618451725973177
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14945,99,1.09 [0.84-1.43],0.5188830293219029
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12595,95,0.94 [0.69-1.28],0.6885094697040588
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18198,123,1.17 [0.95-1.43],0.138377223691724
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12928,428,1.04 [0.91-1.18],0.5446584456602039
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19601,278,1.03 [0.87-1.21],0.7384448073802676
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18721,655,1.04 [0.94-1.16],0.415339020900522
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18985,919,1.02 [0.93-1.12],0.6524505101211924
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13813,178,1.05 [0.86-1.28],0.6322783568351005
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oesophagitis,14221,586,1.01 [0.90-1.13],0.9152416277227412
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19573,113,1.18 [0.96-1.45],0.1225747278771865
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14916,70,1.18 [0.91-1.54],0.2135406181888395
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13658,1158,1.01 [0.93-1.09],0.8423418864373002
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18065,296,0.92 [0.76-1.10],0.3377829323769756
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17892,123,1.03 [0.80-1.31],0.835909002576916
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of intestine,14135,1635,0.99 [0.92-1.06],0.7089394551771404
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of intestines,17681,5181,1.00 [0.96-1.04],0.910130973364068
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18898,181,1.11 [0.93-1.34],0.2436580586074843
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of liver,19388,637,1.01 [0.90-1.12],0.9076772534595696
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14271,636,1.04 [0.94-1.16],0.4363255526401508
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17938,169,1.10 [0.90-1.33],0.342680466145762
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19485,354,1.03 [0.89-1.19],0.7105067389942494
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14551,916,1.02 [0.94-1.12],0.5997095753184131
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19134,1059,1.01 [0.92-1.10],0.8977650507868724
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19088,147,1.10 [0.89-1.35],0.3856874643147494
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14269,1769,0.93 [0.87-1.00],0.0677273328868321
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15465,1830,0.99 [0.93-1.06],0.7797377221103764
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18849,98,1.07 [0.82-1.38],0.6251493646226376
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18880,814,1.02 [0.93-1.12],0.6922683646948377
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12869,369,0.90 [0.76-1.06],0.1986760898669267
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19591,22,0.74 [0.33-1.66],0.4721728364143408
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13017,517,0.96 [0.84-1.09],0.5491100424795285
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18215,140,0.83 [0.62-1.11],0.2011965496168362
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19610,44,0.85 [0.52-1.41],0.5326838053765548
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18933,84,0.89 [0.63-1.26],0.5035805143526275
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Toxic colitis,18139,73,1.09 [0.81-1.46],0.5585375110138979
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13929,294,0.99 [0.83-1.16],0.8614953263787273
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ulcerative colitis,18206,140,1.05 [0.84-1.31],0.6540024656946399
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18179,113,0.91 [0.68-1.22],0.51857157057337
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Umbilical hernia,15061,215,0.96 [0.79-1.17],0.6811660841388443
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12705,205,0.98 [0.80-1.19],0.8113354616569969
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Ventral hernia,15075,229,1.00 [0.83-1.20],0.9731258723873536
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XI Diseases of the digestive system,Volvulus,12577,77,1.33 [1.07-1.66],0.0108159064888174
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19532,352,0.98 [0.84-1.15],0.8092117813608988
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19315,62,0.54 [0.30-0.96],0.03595663555764
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17507,142,1.01 [0.80-1.27],0.9591182459113784
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19093,691,1.01 [0.91-1.13],0.7835104293249844
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18520,118,1.02 [0.79-1.31],0.8718807486693196
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17858,493,1.03 [0.91-1.16],0.680444399192017
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19323,262,0.90 [0.74-1.09],0.2923667673330224
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19527,466,0.93 [0.81-1.07],0.3070269223511603
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19104,43,0.78 [0.45-1.35],0.3665427490720438
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18276,3134,1.00 [0.95-1.05],0.8982311005536167
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19262,364,0.97 [0.83-1.13],0.6654450206733324
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19148,250,0.94 [0.78-1.14],0.5408639806132719
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19295,893,1.04 [0.95-1.14],0.4265918388916253
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19605,49,1.14 [0.82-1.59],0.4275430308177107
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17421,56,0.98 [0.67-1.44],0.922988781247625
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18952,54,0.93 [0.61-1.41],0.7271930884906033
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19311,250,0.91 [0.75-1.11],0.3660049895978079
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17877,512,0.93 [0.81-1.07],0.2969204668201109
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17443,78,1.21 [0.94-1.56],0.137761070260506
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19550,71,0.92 [0.64-1.33],0.6556319455730908
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18580,178,1.13 [0.94-1.36],0.1963407973332074
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19448,195,1.02 [0.84-1.24],0.8211898589521313
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19137,76,1.15 [0.87-1.52],0.3192775600467534
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17428,63,1.01 [0.71-1.44],0.955454330148918
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19105,1740,1.05 [0.98-1.12],0.1663671059911634
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17915,550,0.97 [0.86-1.10],0.6760392549725414
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17446,81,1.19 [0.92-1.53],0.1868732774029801
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19544,291,1.02 [0.87-1.19],0.82690660516626
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19127,66,0.86 [0.58-1.29],0.4764494213123815
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19494,241,0.98 [0.82-1.18],0.8689327959365684
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19561,381,0.97 [0.83-1.13],0.683415185207419
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17471,106,1.05 [0.81-1.36],0.7223372505578259
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17645,280,1.10 [0.95-1.28],0.2057410554485461
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19549,369,0.97 [0.83-1.13],0.6708186374349971
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17631,266,0.90 [0.74-1.09],0.2658981014826413
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19598,119,1.01 [0.78-1.30],0.9579293281543682
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16385,69,1.11 [0.83-1.49],0.4856116298432927
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17316,5417,1.03 [0.99-1.07],0.1315654458558445
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16137,4238,1.04 [0.99-1.08],0.0919867379858597
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16361,45,0.85 [0.52-1.40],0.5315479884286136
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16349,118,1.15 [0.93-1.44],0.1999353013984667
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16384,153,1.04 [0.84-1.30],0.7104159698193846
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19407,51,1.09 [0.76-1.55],0.6415008176845537
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16355,124,1.04 [0.82-1.33],0.7488587025849105
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13152,1253,1.06 [0.99-1.15],0.0990569254040124
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19441,211,1.10 [0.93-1.31],0.2766152596448944
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16698,467,0.95 [0.83-1.09],0.4903212969007554
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15900,6771,1.03 [0.99-1.06],0.1154664121858185
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17517,106,1.14 [0.90-1.44],0.2695234431750696
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16466,150,0.94 [0.73-1.20],0.6071614853103149
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16743,427,1.10 [0.97-1.24],0.1307611861745353
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18820,2589,1.04 [0.99-1.10],0.1052096271034887
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16578,262,0.82 [0.66-1.02],0.0701381124095961
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16437,121,1.16 [0.95-1.43],0.1465972200917597
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16414,98,1.18 [0.94-1.49],0.1446474584976186
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18960,87,0.74 [0.49-1.10],0.1342112543610746
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13606,1707,0.97 [0.90-1.04],0.3436806986041166
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12535,636,1.10 [0.99-1.21],0.0635660984518567
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19537,630,1.12 [1.01-1.23],0.0336669311426276
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11958,59,1.01 [0.69-1.46],0.9694933632811722
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12159,260,1.06 [0.90-1.25],0.4963208894038033
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16539,223,0.97 [0.80-1.18],0.7486227182807523
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12315,416,1.08 [0.95-1.23],0.2348234136050651
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16296,65,1.11 [0.82-1.51],0.4924304334841851
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16791,560,1.09 [0.98-1.21],0.1106066817115666
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16481,250,0.96 [0.79-1.15],0.6312687016617049
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12288,389,1.07 [0.94-1.23],0.2941779978472864
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16377,61,1.23 [0.94-1.63],0.1358353993481936
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16362,46,1.19 [0.85-1.65],0.3147507941556432
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17477,66,1.16 [0.87-1.55],0.3207346264400086
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19260,1849,1.05 [0.99-1.12],0.1071327732362869
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18714,1303,1.04 [0.96-1.12],0.3156872774405053
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19481,459,1.01 [0.88-1.15],0.9280043545591
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14541,2642,1.06 [1.00-1.11],0.0446853262044206
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11937,38,0.80 [0.45-1.42],0.4429739321765505
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16401,85,0.73 [0.48-1.10],0.1296641719971127
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11962,63,1.16 [0.85-1.57],0.344999454068158
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12015,116,0.97 [0.74-1.28],0.8281535667903991
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17612,201,1.09 [0.91-1.31],0.3418628134424961
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17816,405,1.02 [0.89-1.17],0.7712584157771138
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19605,88,0.96 [0.70-1.31],0.7762003308023442
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17863,1632,1.04 [0.98-1.12],0.2082415059947104
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16375,59,0.97 [0.66-1.41],0.8614989898000313
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12026,127,0.89 [0.67-1.18],0.4186650111509881
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16886,655,1.02 [0.92-1.14],0.7049684809112174
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13728,1829,1.04 [0.98-1.11],0.1844287250333799
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18981,108,0.73 [0.51-1.05],0.0866268608884376
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19614,59,0.53 [0.29-0.96],0.0374639894973229
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16383,67,0.90 [0.61-1.32],0.5975180675219869
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17435,1119,1.03 [0.95-1.12],0.4798007373997853
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16403,87,0.79 [0.54-1.16],0.2252850774031768
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13645,1746,0.97 [0.91-1.04],0.4361366623867315
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17511,100,1.12 [0.88-1.44],0.3569201348583385
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16342,26,1.21 [0.79-1.86],0.3762028520857463
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16394,163,0.78 [0.59-1.03],0.0810933702484078
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16883,567,0.94 [0.83-1.06],0.3173643182862214
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19295,422,0.97 [0.84-1.12],0.6873037063951667
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16768,537,1.01 [0.89-1.14],0.9207766226093568
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19493,455,1.03 [0.90-1.17],0.6805880517105112
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19599,56,0.77 [0.47-1.24],0.2790576357792165
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16453,137,0.97 [0.75-1.24],0.7866836015767248
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15290,717,1.01 [0.91-1.12],0.8406267868527516
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16847,531,1.05 [0.94-1.18],0.377384797649076
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16551,235,0.83 [0.66-1.04],0.1088521980904479
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11962,63,1.04 [0.74-1.47],0.8206662273963424
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14515,2616,1.00 [0.95-1.06],0.9381897689856836
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12598,699,1.08 [0.98-1.19],0.1354150027339119
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19185,312,0.96 [0.81-1.13],0.5921833457204793
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19578,61,0.97 [0.67-1.40],0.8595183085464022
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17368,57,1.03 [0.72-1.45],0.8836104107491835
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11959,60,0.55 [0.31-0.99],0.0462459697206032
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16322,91,0.97 [0.71-1.31],0.8208479180363751
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12364,465,1.02 [0.89-1.16],0.7969416757213539
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16600,284,1.13 [0.98-1.30],0.0998640460690602
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16466,235,1.00 [0.83-1.20],0.9996192518160504
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16449,218,0.87 [0.69-1.08],0.2053334727701272
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13821,59,1.04 [0.73-1.47],0.8289806091894583
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19603,60,0.80 [0.51-1.25],0.3199197154562144
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16785,469,1.07 [0.95-1.21],0.2370650036095047
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],18961,88,0.94 [0.69-1.29],0.7223820510932112
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18519,2203,1.01 [0.95-1.07],0.7429373518807924
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16440,124,1.00 [0.78-1.29],0.998175508026908
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16797,566,1.04 [0.92-1.16],0.5514740041484443
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18443,222,0.82 [0.65-1.03],0.0861749062570139
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16427,196,0.95 [0.77-1.18],0.6397889756353945
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17855,1624,1.06 [0.99-1.13],0.0743130087507021
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17296,1065,1.07 [0.99-1.16],0.0765632250288409
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16364,48,0.50 [0.26-0.99],0.0476320022986881
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18983,110,1.03 [0.80-1.33],0.8083160594433613
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16460,144,1.20 [0.99-1.44],0.0570819131281326
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16395,79,0.91 [0.65-1.29],0.6015224188912227
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11960,61,0.78 [0.49-1.26],0.3112290471842337
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18503,1790,1.04 [0.98-1.11],0.2271884247987421
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7909,22,1.04 [0.59-1.83],0.8927105074022392
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10038,28,1.16 [0.75-1.77],0.5040377331952163
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19350,260,0.94 [0.78-1.14],0.5429546130115745
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19178,88,0.85 [0.59-1.22],0.3775786849928882
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18429,1716,1.02 [0.96-1.09],0.5041087705771767
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19439,87,1.07 [0.82-1.41],0.6143209675894228
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19402,330,1.04 [0.89-1.20],0.6357707790959404
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Cystitis,16472,255,1.07 [0.90-1.25],0.4487163396523098
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Dialysis,16782,69,1.06 [0.76-1.46],0.7445401897534105
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8595,1774,0.99 [0.92-1.06],0.7261451486239221
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10118,108,1.14 [0.90-1.42],0.2734075363070079
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Endometriosis,7921,34,1.05 [0.67-1.65],0.8203529410421888
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8369,482,0.92 [0.81-1.06],0.2597147358415904
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16209,5186,0.99 [0.96-1.03],0.7851994984990474
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19420,68,0.72 [0.45-1.13],0.1487274231737191
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Hydrocele,6923,102,1.00 [0.75-1.33],0.9925019600957532
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16737,272,0.97 [0.82-1.16],0.7795439631063193
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8333,1512,1.01 [0.93-1.09],0.8487580824202301
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10174,137,1.07 [0.86-1.33],0.5494728663156642
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6924,103,0.81 [0.57-1.15],0.238649175586777
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16287,70,1.03 [0.75-1.43],0.836780006169119
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8756,869,1.01 [0.92-1.11],0.8668591212205154
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6871,50,1.15 [0.82-1.62],0.4034474032881132
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7920,33,1.05 [0.66-1.66],0.8379214406390731
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19615,75,0.96 [0.69-1.35],0.8255609766850105
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19610,74,1.09 [0.82-1.47],0.5516793556686153
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18613,2396,1.00 [0.94-1.06],0.890449672025245
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17004,787,0.92 [0.82-1.03],0.1494222846412141
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10055,45,1.18 [0.84-1.65],0.3386915713126555
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19560,488,1.05 [0.93-1.18],0.434481423764221
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6942,121,1.03 [0.80-1.33],0.8014251648972326
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6958,137,0.96 [0.74-1.24],0.7469087278436609
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6944,123,0.81 [0.58-1.12],0.2024022844763417
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19590,69,1.16 [0.88-1.54],0.288486857044815
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18091,1874,1.00 [0.93-1.06],0.9370623318553668
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10108,71,0.90 [0.63-1.30],0.5902465314196839
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7950,63,1.03 [0.74-1.43],0.8526746266225576
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8018,131,1.15 [0.94-1.40],0.1881631478812903
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7935,48,0.90 [0.58-1.39],0.6287326138785645
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7972,85,1.05 [0.79-1.39],0.7500636945011301
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16787,322,0.99 [0.84-1.16],0.9114853690463012
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19226,154,1.06 [0.85-1.31],0.6215781800278142
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7993,106,1.03 [0.80-1.34],0.7984900698151053
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7909,22,0.57 [0.23-1.45],0.2409121867721887
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8070,183,1.08 [0.89-1.30],0.4277253218664867
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7967,80,1.00 [0.73-1.36],0.9809729623251664
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8061,174,1.26 [1.09-1.47],0.0025877768317969
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19399,47,1.15 [0.81-1.64],0.4192880553201974
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6946,125,1.17 [0.94-1.44],0.1563647942239186
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19419,2954,1.02 [0.97-1.08],0.3520408827618139
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16542,77,0.85 [0.58-1.24],0.385679998586013
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16851,138,1.14 [0.93-1.40],0.2199311974392445
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19120,30,1.18 [0.78-1.80],0.4238751268811066
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16442,225,0.88 [0.71-1.09],0.2533910593355455
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19423,333,0.95 [0.81-1.12],0.5471025343381597
RAC3,Ras-related C3 botulinum toxin substrate 3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7920,33,0.57 [0.27-1.22],0.150251473211347
